Oral Microbiome in Carotid Atherosclerosis
Recruiting
Observational Study
Atherosclerosis Cardiovascular Disease
Atherosclerosis of Artery
Carotid Artery Plaque
Periodontitis
Carotid Artery Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Semmelweis University Heart and Vascular Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study, called OMICA (Oral Microbiome in Carotid Atherosclerosis), is to learn how bacteria living in the mouth may influence the development and stability of plaques in the carotid arteries, which supply blood to the brain. Plaque buildup in these arteries can lead to stroke.
Researchers want to understand whether certain oral bacteria are linked to plaque vulnerabi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Confirmed internal carotid artery (ICA) stenosis on preoperative photon-counting computed tomography (CTA)
* Adults (≥18 years) undergoing carotid endarterectomy at Semmelweis University.
* Eligible for surgery based on standard anesthesiologic evaluation.
* Willing and able t…
Contacts